Showing 261-270 of 8874 results for "".
Pediatric Atopic Dermatitis And Psoriasis
https://practicaldermatology.com/topics/psoriasis/pediatric-atopic-dermatitis-and-psoriasis/18631/Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many children remain undertreated for their eczema despite the availability of effective treatments and a number of topical and systemic products on the horizon. Dr. Eichenfield also proThe Rising Costs of Prescription Drugs
https://practicaldermatology.com/topics/practice-management/the-rising-costs-or-prescription-drugs/18677/What's really causing the costs of dermatology prescriptions, especially generics, to skyrocket? Jake Levitt, MD and Mark Lebwohl, MD speak to host Neal Bhatia, MD about what's influencing these rising costs, and who, if anyone, is benefiting. Dr. Levitt talks about the rebate system between manufacPsoriasis: Guidelines and Clinical Pearls
https://practicaldermatology.com/topics/general-topics/psoriasis-guidelines-and-clinical-pearls/19339/Psoriasis specialist Jerry Bagel, MD speaks with host Joshua Zeichner, MD about new Treatment Guidelines, their impact on clinical decision making, and his own approach to patient care. Watch now for tips on patient management and treatment selection. Bonus Material: Dr. Bagel addresses the subjectThe Future of Laser and Device-based Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-future-of-laser-and-device-based-procedures/19345/New technologies and economic pressures on clinicians ensure a promising future for aesthetic laser treatment, according to Dr. Eric Bernstein.Dealing With Unhappy Cosmetic Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dealing-with-unhappy-cosmetic-patients/23870/Tips on avoiding and appeasing difficult patients.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.Peri-Procedural Skincare: A Look at the Evidence
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/peri-procedural-skincare-a-look-at-the-evidence/23786/Evidence shows that the use of appropriate topical skincare products before and after procedures can enhance outcomes.Establishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Professionalism in the Workplace: Tips for Managers
https://practicaldermatology.com/topics/practice-management/professionalism-in-the-workplace-tips-for-managers/20514/Maintaining the highest possible level of professionalism can help new and seasoned managers navigate challenges and position themselves to take advantage of additional opportunities.Long-Term Bimzelx Data Presented
https://practicaldermatology.com/series/dermwire-tv/long-term-bimzelx-data-presented/35563/In this week's DermwireTV, new long-term data is presented for Bimzelx (bimekizumab-bkzx) for two indications; an analysis examines the correlation between proximity to tanning facilities and melanoma incidence; and in our C-Suite Chats feature, we hear from the Founder and CEO of Joya Health.